文献速递关节外科

基于假体品牌比较全膝关节置换术患者报告结局的前瞻性队列研究

Comparison of patient-reported outcomes based on implant brand in total knee arthroplasty: a prospective cohort study.
PubMed 文献 · Bone Joint J · 2019-01-01

该前瞻性队列研究利用机构登记数据,纳入4135例因骨关节炎行初次全膝关节置换术并使用五种后稳定型假体品牌的患者,比较术前与术后两年KOOS、LEAS、SF-12及满意度评分。多因素回归分析显示各组KOOS评分变化无临床显著差异,各组满意度均超过80%,NexGen组满意可能性最高(OR 1.63;p=0.006),Optetrak Logic组最低(OR 0.60;p<0.001)。结论认为全膝关节置换术无论假体类型均可改善功能与满意度,未能证明任一设计优于其他。

要点

  • 五种后稳定型假体品牌术后两年KOOS评分变化无临床显著差异。
  • 各组满意度均超过80%,NexGen组满意可能性最高(OR 1.63;p=0.006)。
  • Optetrak Logic组满意可能性最低(OR 0.60;p<0.001)。

核心结论

  • 全膝关节置换术无论假体类型均可改善功能与满意度。
  • 未能证明任一假体设计优于其他设计,任一系统相对于其他系统的价格溢价可能缺乏依据。
  • 医疗管理者在采购合同谈判时可能发现这些结局相似性有帮助。

研究设计与样本

  • 前瞻性队列研究,利用机构登记数据纳入4135例因骨关节炎行初次全膝关节置换术并使用五种最常见后稳定型假体品牌的患者。
  • Biomet Vanguard组211例,DePuy/Johnson & Johnson Sigma组222例,Exactech Optetrak Logic组1508例,Smith & Nephew Genesis II组1415例,Zimmer NexGen组779例。
  • 术前评估KOOS、LEAS、SF-12,收集年龄、体重指数、Charlson合并症指数、美国麻醉医师协会分级、性别和吸烟状态。
  • 术后两年比较KOOS、LEAS、SF-12和满意度评分。

主要发现

  • 术后两年结局数据可获取4069例(98%)。
  • 多因素回归分析分别比较每个假体组与其余所有组合并后,各组KOOS评分从基线至术后两年随访的变化无临床显著差异。
  • 术后两年各组在所有领域满意度均超过80%。
  • 多变量回归模型中,NexGen组患者满意可能性最高(OR 1.63;p=0.006)。
  • Optetrak Logic组患者满意可能性最低(OR 0.60;p<0.001)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The outcomes of total knee arthroplasty (TKA) depend on many factors. The impact of implant design on patient-reported outcomes is unknown. Our goal was to evaluate the patient-reported outcomes and satisfaction after primary TKA in patients with osteoarthritis undergoing primary TKA using five different brands of posterior-stabilized implant. PATIENTS AND METHODS: Using our institutional registry, we identified 4135 patients who underwent TKA using one of the five most common brands of implant. These included Biomet Vanguard (Zimmer Biomet, Warsaw, Indiana) in 211 patients, DePuy/Johnson & Johnson Sigma (DePuy Synthes, Raynham, Massachusetts) in 222, Exactech Optetrak Logic (Exactech, Gainesville, Florida) in 1508, Smith & Nephew Genesis II (Smith & Nephew, London, United Kingdom) in 1415, and Zimmer NexGen (Zimmer Biomet) in 779 patients. Patients were evaluated preoperatively using the Knee Injury and Osteoarthritis Outcome Score (KOOS), Lower Extremity Activity Scale (LEAS), and 12-Item Short-Form Health Survey questionnaire (SF-12). Demographics including age, body mass index, Charlson Comorbidity Index, American Society of Anethesiologists status, sex, and smoking status were collected. Postoperatively, two-year KOOS, LEAS, SF-12, and satisfaction scores were compared between groups. RESULTS: Outcomes were available for 4069 patients (98%) at two years postoperatively. In multiple regression analysis, which separately compared each implant group with the aggregate of all others, there were no clinically significant differences in the change of KOOS score from baseline to two-year follow-up between any of the groups. More than 80% of patients in each group were satisfied at this time in all domains. In a multivariate regression model, patients in the NexGen group were the most likely to be satisfied (odds ratio (OR) 1.63; p = 0.006) and Optetrak Logic patients were the least likely to be satisfied (OR 0.60; p < 0.001). CONCLUSION: TKA provides improvement in function and satisfaction regardless of the type of implant. We could not demonstrate superiority of one design above others across these groups of implants, and any price premium for one above the other systems may not be justified. Healthcare administrators may find these similarities in outcomes helpful when negotiating purchasing contracts. Cite this article: Bone Joint J 2019;101-B(7 Supple C):48-54.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Kahlenberg CA, Lyman S, Joseph AD, et al. Comparison of patient-reported outcomes based on implant brand in total knee arthroplasty: a prospective cohort study. Bone Joint J. 2019. PMID: 31256639. doi:10.1302/0301-620X.101B7.BJJ-2018-1382.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。